{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:35:54Z","timestamp":1791286554428,"version":"4.1.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T00:00:00Z","timestamp":1373414400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0067839","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T21:03:40Z","timestamp":1373490220000},"page":"e67839","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Background Strain and the Differential Susceptibility of Podocyte-Specific Deletion of Myh9 on Murine Models of Experimental Glomerulosclerosis and HIV Nephropathy"],"prefix":"10.1371","volume":"8","author":[{"given":"Duncan B.","family":"Johnstone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Ikizler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence B.","family":"Holzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,7,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/01.md.0000076006.64510.5c","article-title":"MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness","volume":"82","author":"M Seri","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1053\/j.ajkd.2009.06.023","article-title":"CKD in MYH9-related disorders","volume":"54","author":"N Singh","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1128\/MCB.05234-11","article-title":"Podocyte-Specific Deletion of Myh9 Encoding Nonmuscle Myosin Heavy Chain 2A Predisposes Mice to Glomerulopathy","volume":"31","author":"DB Johnstone","year":"2011","journal-title":"Mol Cell Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ng.226","article-title":"MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis","volume":"40","author":"JB Kopp","year":"2008","journal-title":"Nat Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ng.232","article-title":"MYH9 is associated with nondiabetic end-stage renal disease in African Americans","volume":"40","author":"WH Kao","year":"2008","journal-title":"Nat Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/hmg\/ddq040","article-title":"African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans","volume":"19","author":"DM Behar","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/hmg\/ddq039","article-title":"Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15","volume":"19","author":"GW Nelson","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref8","article-title":"Association of Trypanolytic ApoL1 Variants with Kidney Disease in African-Americans","author":"G Genovese","year":"2010","journal-title":"Science"},{"key":"ref9","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","author":"S Tzur","year":"2010","journal-title":"Hum Genet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1681\/ASN.2010070730","article-title":"The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans","volume":"21","author":"BI Freedman","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2011.08832.x","article-title":"MYH9 and APOL1 are both associated with sickle cell disease nephropathy","volume":"155","author":"AE Ashley-Koch","year":"2011","journal-title":"Br J Haematol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/ndt\/gfr522","article-title":"Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans","volume":"27","author":"JN Cooke","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1093\/hmg\/ddr118","article-title":"The MYH9\/APOL1 region and chronic kidney disease in European-Americans","volume":"20","author":"CM O'Seaghdha","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1681\/ASN.2011040434","article-title":"APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy","volume":"22","author":"N Papeta","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/gene.2011.82","article-title":"Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis","volume":"13","author":"CP Lin","year":"2012","journal-title":"Genes Immun"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000314688","article-title":"The Non-Muscle Myosin Heavy Chain 9 Gene (MYH9) Is Not Associated with Lupus Nephritis in African Americans","volume":"32","author":"BI Freedman","year":"2010","journal-title":"Am J Nephrol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"41263","DOI":"10.1074\/jbc.C400352200","article-title":"Defects in cell adhesion and the visceral endoderm following ablation of nonmuscle myosin heavy chain II-A in mice","volume":"279","author":"MA Conti","year":"2004","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1242\/jcs.007112","article-title":"Nonmuscle myosin II moves in new directions","volume":"121","author":"MA Conti","year":"2008","journal-title":"J Cell Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood-2011-06-358853","article-title":"Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A","volume":"119","author":"Y Zhang","year":"2012","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1172\/JCI43721","article-title":"Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice","volume":"120","author":"N Papeta","year":"2010","journal-title":"J Clin Invest"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1172\/JCI37131","article-title":"Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression","volume":"119","author":"N Papeta","year":"2009","journal-title":"J Clin Invest"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI39492","article-title":"Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice","volume":"120","author":"B Hartleben","year":"2010","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2353\/ajpath.2008.071149","article-title":"Deletion of CD151 results in a strain-dependent glomerular disease due to severe alterations of the glomerular basement membrane","volume":"173","author":"RM Baleato","year":"2008","journal-title":"Am J Pathol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1073\/pnas.89.5.1577","article-title":"Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes","volume":"89","author":"JB Kopp","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev-med-041610-134224","article-title":"Recent progress in HIV-associated nephropathy","volume":"63","author":"CM Wyatt","year":"2012","journal-title":"Annu Rev Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1073\/pnas.0308649100","article-title":"Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3","volume":"101","author":"AG Gharavi","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20051900","article-title":"Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors","volume":"203","author":"Y Kaneko","year":"2006","journal-title":"J Exp Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/labinvest.3780451","article-title":"Decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis","volume":"82","author":"F Lin","year":"2002","journal-title":"Lab Invest"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.4049\/jimmunol.172.4.2636","article-title":"Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritis","volume":"172","author":"F Lin","year":"2004","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1172\/JCI0214861","article-title":"Essential role of Gas6 for glomerular injury in nephrotoxic nephritis","volume":"110","author":"M Yanagita","year":"2002","journal-title":"J Clin Invest"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI0214574","article-title":"IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis","volume":"109","author":"M Shinozaki","year":"2002","journal-title":"J Clin Invest"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1681\/ASN.2009090887","article-title":"Blockade of the kinin B1 receptor ameloriates glomerulonephritis","volume":"21","author":"J Klein","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1681\/ASN.2005020167","article-title":"Activation of Galpha q-coupled signaling pathways in glomerular podocytes promotes renal injury","volume":"16","author":"L Wang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1093\/hmg\/ddp328","article-title":"Genetics of nephrotic syndrome: connecting molecular genetics to podocyte physiology","volume":"18","author":"E Machuca","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.4049\/jimmunol.0802413","article-title":"Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2","volume":"182","author":"AY Higashi","year":"2009","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1074\/jbc.M512373200","article-title":"RIP-Cre revisited, evidence for impairments of pancreatic beta-cell function","volume":"281","author":"JY Lee","year":"2006","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2105-5-14","article-title":"Comparison of computational methods for identifying translation initiation sites in EST data","volume":"5","author":"A Nadershahi","year":"2004","journal-title":"BMC Bioinformatics"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/bioinformatics\/14.5.384","article-title":"Assessing protein coding region integrity in cDNA sequencing projects","volume":"14","author":"AA Salamov","year":"1998","journal-title":"Bioinformatics"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1083\/jcb.152.5.959","article-title":"Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules","volume":"152","author":"KJ Verhey","year":"2001","journal-title":"J Cell Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/ni.1936","article-title":"Confinement-optimized three-dimensional T cell amoeboid motility is modulated via myosin IIA-regulated adhesions","volume":"11","author":"J Jacobelli","year":"2010","journal-title":"Nat Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bbrc.2004.10.147","article-title":"Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice","volume":"325","author":"T Matsushita","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12017-007-8008-8","article-title":"Generation and characterization of mice with Myh9 deficiency","volume":"9","author":"AN Mhatre","year":"2007","journal-title":"Neuromolecular Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1159\/000317130","article-title":"Permeability, ultrastructural changes, and distribution of novel proteins in the glomerular barrier in early puromycin aminonucleoside nephrosis","volume":"116","author":"F Duner","year":"2010","journal-title":"Nephron Exp Nephrol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0067839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T16:36:21Z","timestamp":1540226181000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0067839"}},"subtitle":[],"editor":[{"given":"Stuart E.","family":"Dryer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,10]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0067839","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,10]]}}}